Active Ingredient(s): Melphalan
FDA Approved: * January 17, 1964
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Alkeran Overview

Melphalan, sold under the trade name Alkeran among others, is a chemotherapy medication used to treat multiple myeloma, ovarian cancer, melanoma, and AL amyloidosis.[1] It is taken as a tablet (by mouth) or by injection into a vein.[1] Common side effects include nausea and bone marrow suppression.[1] Other severe side effects may include anaphylaxis and the development of other cancers.[1] Use during pregnancy may result in harm...

Read more Alkeran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Alkeran Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 20mg, 50mg, 50mg/vial
  • Powder: 20mg/vial, 50mg/vial
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Alkeran: (3 results)

Sorted by National Drug Code
  • 52609-0001 Alkeran 2 mg Oral Tablet by Apo-pharma USA, Inc
  • 52609-3001 Alkeran Kit by Apo-pharma USA, Inc
  • 63379-018 Alkeran Kit by Glaxo Operations Uk Ltd

Other drugs which contain Melphalan or a similar ingredient: (3 results)